ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Shionogi to ready COVID-19 vaccines for 30m people

Japanese drugmaker to lift capacity for coronavirus treatments by end of 2021

Japanese pharmaceutical maker Shionogi hopes to make COVID-19 vaccines for 30 million people a year by the end of 2021. (Source photo by screenshot from Shionogi website and photo courtesy of Shionogi)

TOKYO -- Japanese drugmaker Shionogi plans to increase production capacity for its coronavirus vaccine candidate, aiming to turn out enough vaccines for 30 million people per year by the end of 2021, as competition intensifies to develop COVID-19 treatments, Nikkei has learned.

Shionogi will increase capacity at its plant by more than tripling its previous capacity by adding manufacturing equipment. It plans to carry out all phases of production, including procurement of materials, in Japan.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more